These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36765718)

  • 1. Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status.
    Eyraud R; Ayache S; Tsvetkov PO; Kalidindi SS; Baksheeva VE; Boissonneau S; Jiguet-Jiglaire C; Appay R; Nanni-Metellus I; Chinot O; Devred F; Tabouret E
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An AI-Powered Blood Test to Detect Cancer Using NanoDSF.
    Tsvetkov PO; Eyraud R; Ayache S; Bougaev AA; Malesinski S; Benazha H; Gorokhova S; Buffat C; Dehais C; Sanson M; Bielle F; Figarella Branger D; Chinot O; Tabouret E; Devred F
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tear nanoDSF Denaturation Profile Is Predictive of Glaucoma.
    Baksheeva VE; Tiulina VV; Iomdina EN; Petrov SY; Filippova OM; Kushnarevich NY; Suleiman EA; Eyraud R; Devred F; Serebryakova MV; Shebardina NG; Chistyakov DV; Senin II; Mitkevich VA; Tsvetkov PO; Zernii EY
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential scanning calorimetry of plasma in glioblastoma: toward a new prognostic / monitoring tool.
    Tsvetkov PO; Tabouret E; Roman AY; Romain S; Bequet C; Ishimbaeva O; Honoré S; Figarella-Branger D; Chinot O; Devred F
    Oncotarget; 2018 Feb; 9(10):9391-9399. PubMed ID: 29507697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current role of machine learning and radiogenomics in precision neuro-oncology.
    Perillo T; de Giorgi M; Papace UM; Serino A; Cuocolo R; Manto A
    Explor Target Antitumor Ther; 2023; 4(4):545-555. PubMed ID: 37720347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.
    Schaff LR; Yan D; Thyparambil S; Tian Y; Cecchi F; Rosenblum M; Reiner AS; Panageas KS; Hembrough T; Lin AL
    J Neurooncol; 2020 Jan; 146(1):163-170. PubMed ID: 31823165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.
    Pfaff E; Kessler T; Balasubramanian GP; Berberich A; Schrimpf D; Wick A; Debus J; Unterberg A; Bendszus M; Herold-Mende C; Capper D; Schenkel I; Eisenmenger A; Dettmer S; Brors B; Platten M; Pfister SM; von Deimling A; Jones DTW; Wick W; Sahm F
    Neuro Oncol; 2018 May; 20(6):826-837. PubMed ID: 29165638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
    Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
    Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of
    Brandes AA; Franceschi E; Paccapelo A; Tallini G; De Biase D; Ghimenton C; Danieli D; Zunarelli E; Lanza G; Silini EM; Sturiale C; Volpin L; Servadei F; Talacchi A; Fioravanti A; Pia Foschini M; Bartolini S; Pession A; Ermani M
    Oncologist; 2017 Apr; 22(4):432-437. PubMed ID: 28275120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
    Nguyen AV; Blears EE; Ross E; Lall RR; Ortega-Barnett J
    Neurosurg Focus; 2018 Nov; 45(5):E5. PubMed ID: 30453459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approach.
    Do DT; Yang MR; Lam LHT; Le NQK; Wu YW
    Sci Rep; 2022 Aug; 12(1):13412. PubMed ID: 35927323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.
    Vaios EJ; Nahed BV; Muzikansky A; Fathi AT; Dietrich J
    J Neurosurg; 2017 Jul; 127(1):132-138. PubMed ID: 27739940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics-based machine learning model for efficiently classifying transcriptome subtypes in glioblastoma patients from MRI.
    Le NQK; Hung TNK; Do DT; Lam LHT; Dang LH; Huynh TT
    Comput Biol Med; 2021 May; 132():104320. PubMed ID: 33735760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.
    Lee MH; Kim J; Kim ST; Shin HM; You HJ; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
    World Neurosurg; 2019 May; 125():e688-e696. PubMed ID: 30735871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
    Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
    Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma.
    Verduin M; Primakov S; Compter I; Woodruff HC; van Kuijk SMJ; Ramaekers BLT; te Dorsthorst M; Revenich EGM; ter Laan M; Pegge SAH; Meijer FJA; Beckervordersandforth J; Speel EJ; Kusters B; de Leng WWJ; Anten MM; Broen MPG; Ackermans L; Schijns OEMG; Teernstra O; Hovinga K; Vooijs MA; Tjan-Heijnen VCG; Eekers DBP; Postma AA; Lambin P; Hoeben A
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
    Brown KE; Chagoya G; Kwatra SG; Yen T; Keir ST; Cooter M; Hoadley KA; Rasheed A; Lipp ES; Mclendon R; Ali-Osman F; Bigner DD; Sampson JH; Kwatra MM
    J Neurochem; 2015 Jun; 133(5):730-8. PubMed ID: 25598002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.
    Xiu J; Piccioni D; Juarez T; Pingle SC; Hu J; Rudnick J; Fink K; Spetzler DB; Maney T; Ghazalpour A; Bender R; Gatalica Z; Reddy S; Sanai N; Idbaih A; Glantz M; Kesari S
    Oncotarget; 2016 Apr; 7(16):21556-69. PubMed ID: 26933808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma.
    Kanas VG; Zacharaki EI; Thomas GA; Zinn PO; Megalooikonomou V; Colen RR
    Comput Methods Programs Biomed; 2017 Mar; 140():249-257. PubMed ID: 28254081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing the impact of machine learning and artificial intelligence and its effect on management of lung cancer detection in covid-19 pandemic.
    Boddu RSK; Karmakar P; Bhaumik A; Nassa VK; Vandana ; Bhattacharya S
    Mater Today Proc; 2022; 56():2213-2216. PubMed ID: 34877264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.